2013
DOI: 10.1039/c3cc42179a
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of a photocaged tamoxifen for light-dependent activation of Cre-ER recombinase-driven gene modification

Abstract: We report the design of a water-soluble, quaternized tamoxifen photoprobe and demonstrate its application for light-controlled induction of green fluorescent protein expression via a Cre-ER recombinase system.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
44
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 42 publications
(46 citation statements)
references
References 27 publications
0
44
0
Order By: Relevance
“…UVA is less toxic to most mammalian cells than shorter UVB and UVC, and thus has served as a tool for active control in chemical biology such as protein activation, [3a, 5a, 15] optogenetics, [4a, 4c, 16] and photochemical internalization of biomacromolecules. [17] More recently, applications of light-controlled mechanisms for drug release [13] have been developed by numerous laboratories including ours in the design of prodrugs and drug delivery systems for various therapeutic agents including olaparib (AZD-2281), [11e] melphalan, [11f] methotrexate, [18] doxorubicin (Dox), [10b, 10c, 19] paclitaxel (taxol), [20] 5-fluorouracil, [21] tamoxifen, [4a, 8, 16] and ciprofloxacin. [22] However, efficient implementation of photocage molecules for such applications [13] is often challenging due in part to the synthetic complexity involved in drug and/or reporter conjugation which requires a multistep process.…”
Section: Introductionmentioning
confidence: 99%
“…UVA is less toxic to most mammalian cells than shorter UVB and UVC, and thus has served as a tool for active control in chemical biology such as protein activation, [3a, 5a, 15] optogenetics, [4a, 4c, 16] and photochemical internalization of biomacromolecules. [17] More recently, applications of light-controlled mechanisms for drug release [13] have been developed by numerous laboratories including ours in the design of prodrugs and drug delivery systems for various therapeutic agents including olaparib (AZD-2281), [11e] melphalan, [11f] methotrexate, [18] doxorubicin (Dox), [10b, 10c, 19] paclitaxel (taxol), [20] 5-fluorouracil, [21] tamoxifen, [4a, 8, 16] and ciprofloxacin. [22] However, efficient implementation of photocage molecules for such applications [13] is often challenging due in part to the synthetic complexity involved in drug and/or reporter conjugation which requires a multistep process.…”
Section: Introductionmentioning
confidence: 99%
“…S9, ESI †). Lastly, we tested whether serum concentrations affected ONB 1 -4OHT activity, as it did for ONB-TAM, 22 and observed no dramatic difference in recombination efficiency (Fig. S10, ESI †).…”
Section: Resultsmentioning
confidence: 99%
“…While we previously used the UT MEF reporter system to validate the photorelease of photocaged TAM, 22 it required near toxic concentrations (Z8 mM). Consequently, our initial test of ONB-4OHT compounds used similarly high concentrations (5 mM), and we often observed reduced cell viability after treatment (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations